James O’Beirne

11.0k total citations · 1 hit paper
153 papers, 5.8k citations indexed

About

James O’Beirne is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, James O’Beirne has authored 153 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Hepatology, 93 papers in Epidemiology and 53 papers in Surgery. Recurrent topics in James O’Beirne's work include Liver Disease and Transplantation (76 papers), Liver Disease Diagnosis and Treatment (75 papers) and Organ Transplantation Techniques and Outcomes (29 papers). James O’Beirne is often cited by papers focused on Liver Disease and Transplantation (76 papers), Liver Disease Diagnosis and Treatment (75 papers) and Organ Transplantation Techniques and Outcomes (29 papers). James O’Beirne collaborates with scholars based in United Kingdom, Australia and Italy. James O’Beirne's co-authors include Andrew K. Burroughs, David Patch, Philip J. Johnson, Richard Fox, Emmanuel Tsochatzis, Daniel H. Palmer, Paul B.S. Lai, Stephen L. Chan, Bruno Sangro and Frankie Mo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

James O’Beirne

147 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

2014 1.8k citations James O’Beirne et al. profile →

Peers

Countries citing papers authored by James O’Beirne

Since Specialization

Citations

This map shows the geographic impact of James O’Beirne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James O’Beirne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James O’Beirne more than expected).

Fields of papers citing papers by James O’Beirne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James O’Beirne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James O’Beirne. The network helps show where James O’Beirne may publish in the future.

Co-authorship network of co-authors of James O’Beirne

This figure shows the co-authorship network connecting the top 25 collaborators of James O’Beirne. A scholar is included among the top collaborators of James O’Beirne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James O’Beirne. James O’Beirne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study 2024 ·Public Health ·(unknown), Richard Skoien, Günter Härtel, James O’Beirne, Paul J. Clark, (unknown), Barbara Leggett, Elizabeth E. Powell, Patricia C. Valery	1
2	Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer 2024 ·JGH Open ·Elizabeth E. Powell, (unknown), (unknown), Günter Härtel, Richard Skoien, Barbara Leggett, James O’Beirne, Patricia C. Valery	1
3	An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations 2024 ·Patient Preference and Adherence ·(unknown), (unknown), (unknown), Steven McPhail, Anthony Russell, James O’Beirne, Katharine M. Irvine, Suzanne T. Williams, Patricia C. Valery, Elizabeth E. Powell	0
4	Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres 2024 ·Internal Medicine Journal ·(unknown), (unknown), (unknown), (unknown), Jonathan Mitchell, (unknown), (unknown), Natalie Funakoshi, Jonathan Langton, (unknown), James O’Beirne	0
5	A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia 2024 ·Public Health ·Sameera Senanayake, Adrian Barnett, David Brain, Michelle Allen, Elizabeth E. Powell, James O’Beirne, Patricia C. Valery, Ingrid J. Hickman, Sanjeewa Kularatna	4
6	A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels 2023 ·BMC Health Services Research ·Michelle Allen, (unknown), David Brain, Elizabeth E. Powell, James O’Beirne, Patricia C. Valery, Adrian Barnett, Ruvini M. Hettiarachchi, Ingrid J. Hickman, Sanjeewa Kularatna	2
7	Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists 2023 ·Annals of Hepatology ·(unknown), (unknown), (unknown), Anthony Russell, James O’Beirne, Katharine M. Irvine, Suzanne T. Williams, (unknown), Patricia C. Valery, Kelly L. Hayward, Elizabeth E. Powell	5
8	Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis 2020 ·Internal Medicine Journal ·Patricia C. Valery, Steven McPhail, Katherine Stuart, Günter Härtel, Paul J. Clark, James O’Beirne, Richard Skoien, Tony Rahman, (unknown), Elizabeth E. Powell	17
9	Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care 2020 ·PLoS ONE ·David Brain, Jonathan Mitchell, James O’Beirne	3
10	Review article: the role of the microcirculation in liver cirrhosis 2017 ·Alimentary Pharmacology & Therapeutics ·Thomas Davies, (unknown), James O’Beirne, Daniel Martín, Edward T. Gilbert-Kawai	17
11	Non‐selective beta‐blockers are not associated with increased mortality in cirrhotic patients with ascites 2017 ·Liver International ·Simona Onali, Maria Kalafateli, Avik Majumdar, Rachel Westbrook, James O’Beirne, Gioacchino Leandro, David Patch, Emmanuel Tsochatzis	29
12	Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The royal free hospital cirrhosis glomerular filtration rate 2016 ·Hepatology ·Maria Kalafateli, (unknown), Maria Burniston, Εvangelos Cholongitas, Eleni Theocharidou, Matteo Garcovich, James O’Beirne, Rachel Westbrook, Gioacchino Leandro, Andrew K. Burroughs, Emmanuel Tsochatzis	46
13	OC-034 Outcome Of Patients Considered Unsuitable For Liver Transplantation – A Missed Opportunity For Palliative Care? 2014 ·Gut ·(unknown), Scott A Murray, Brian Hogan, James O’Beirne	3
14	Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation 2012 ·Liver Transplantation ·(unknown), Sanjiv Patel, Bimbi Fernando, James O’Beirne, Susan Mallett	36
15	PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance 2012 ·Gut ·Brian Hogan, Paul Trembling, Sudeep Tanwar, Dominic Yu, James O’Beirne, William Rosenberg	1
16	TIPS OUTCOMES FOR BUDD-CHIARI: A SINGLE TERTIARY CENTRE EXPERIENCE 2011 ·UCL Discovery (University College London) ·Jane Macnaughtan, (unknown), Giovanni Tritto, Michelle Mullan, (unknown), Douglas Thorburn, James O’Beirne, Rajiv Jalan, (unknown), (unknown), (unknown)	1
17	P17 TIPS outcomes for Budd–Chiari: a single tertiary centre experience 2011 ·Gut ·Jane Macnaughtan, Brian Hogan, Giovanni Tritto, Michelle Mullan, Dominic Yu, Douglas Thorburn, James O’Beirne, Rajiv Jalan, David Patch, AK Burroughs	1
18	476 WHICH CORRELATION AMONG HISTOLOGICAL ASSESSMENT OF FIBROSIS, NON-INVASIVE MARKERS AND PORTAL HYPERTENSION IN HCV TRANSPLANTED PATIENTS? 2010 ·Journal of Hepatology ·Graziella Isgrò, Vincenza Calvaruso, Pinelopi Manousou, Tu Vinh Luong, Lorenzo Andreana, S. Maimone, Levansri Makalanda, Laura Marelli, David Patch, Neil M Davies, James O’Beirne, Amar P. Dhillon, AK Burroughs	2
19	Outcome of Recurrent Hepatitis C Virus After Liver Transplantation in a Randomized Trial of Tacrolimus Monotherapy Versus Triple Therapy 2009 ·Liver Transplantation ·Pinelopi Manousou, Dimitrios Samonakis, Εvangelos Cholongitas, David Patch, James O’Beirne, Amar P. Dhillon, Keith Rolles, P. Aiden McCormick, Peter Hayes, Andrew K. Burroughs	44
20	Mycophenolate mofetil: An alternative maintenance immunosuppressant in liver transplantation, which improves renal dysfunction. 1998 ·UCL Discovery (University College London) ·George Papatheodoridis, James O’Beirne, Pramod K. Mistry, (unknown), Keith Rolles, AK Burroughs	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact